By Genpharm’s CEO Karim Smaira

To read the full article click  http://www.lifescienceleader.com/doc/the-mena-pharma-market-an-untapped-opportunity-0001

Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharma. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes.

For more on Life Science Magazine visit http://www.lifescienceleader.com